Harbour BioMed Enters into Long-Term Strategic Collaboration with Lannacheng to Advance Next-Generation Radionuclide Drug Conjugates
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, Dec. 29, 2025 /PRNewswire/ -- Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology and...
Cellid and Jig.jp Jointly Develop AR Glasses
A Breakthrough in Everyday AR Glasses, delivered through Sabae Design, Japan's Only Optical Technology, and Software UX Innovation TOKYO, Dec. 11, 2025 /PRNewswire/ -- Cellid Inc., a developer of displays and spatial recognition engines for...